UW Bioengineering faculty Charles Murry, Michael Regnier and Ruikang Wang, and adjunct faculty Tueng Shen, were inducted to the AIMBE College of Fellows Class of 2016 at the AIMBE Annual Event, which was held April 3-4 in Washington, D.C. 25 Bioengineering core and adjunct faculty are AIMBE Fellows, and this year’s class is the largest elected from BioE since 1993.
Charles Murry is a joint professor of bioengineering, pathology and medicine/cardiology. Dr. Murry is a pioneering cardiac disease researcher, and has been instrumental in discovering new methods for treating damage caused by heart attacks.
Michael Regnier is the Washington Research Foundation Endowed Professor of Bioengineering and Bioengineering Vice Chair for Research. Dr. Regnier studies the cellular and molecular mechanisms of cardiac and skeletal muscle disease, and develops gene therapies and cell/tissue engineering approaches for treating disease.
Ruikang Wang is a professor of bioengineering. Dr. Wang works to develop novel and clinically relevant biomedical imaging techniques for early diagnosis, treatment and management of human diseases.
Tueng Shen is adjunct faculty in the Department of Bioengineering, and a professor and clinician of ophthalmology at UW. Dr. Shen’s research group focuses on developing innovative solutions to treating global blindness by leveraging technological advancements in polymer sciences, microelectronics and modern imaging techniques.
AIMBE, or the American Institute for Medical and Biological Engineering,is a non-profit advocacy organization dedicated to improving lives through medical and biological engineering. AIMBE Fellows represent the top two percent of medical and biological engineers in the United States. Drs. Murry, Regnier, Wang and Shen join a distinguished group of more than 1,000 other fellows from academia,industry and government who have made significant contributions to bioengineering research, industrial practice, and education. Visit AIMBE’s website to learn more.